Thirty subjects participated in a nine-period , randomized , double-blinded , placebo-controlled , crossover , ascending dose , first-in-human study with i.v. infusions of @-@ @ mg kg ( -@ ) h ( -@ ) for @ h and intermediate doses up to @ h.